138 related articles for article (PubMed ID: 6349380)
41. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.
Golay A; Swislocki AL; Chen YD; Jaspan JB; Reaven GM
J Clin Endocrinol Metab; 1986 Aug; 63(2):481-4. PubMed ID: 3522620
[TBL] [Abstract][Full Text] [Related]
42. Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa.
Karczewska-Kupczewska M; Straczkowski M; Adamska A; Nikolajuk A; Otziomek E; Górska M; Kowalska I
Eur J Endocrinol; 2010 Feb; 162(2):235-9. PubMed ID: 19884263
[TBL] [Abstract][Full Text] [Related]
43. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
[TBL] [Abstract][Full Text] [Related]
44. Increased hepatic insulin clearance after Roux-en-Y gastric bypass.
Bojsen-Møller KN; Dirksen C; Jørgensen NB; Jacobsen SH; Hansen DL; Worm D; Naver L; Kristiansen VB; Holst JJ; Madsbad S
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1066-71. PubMed ID: 23609835
[TBL] [Abstract][Full Text] [Related]
45. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
[TBL] [Abstract][Full Text] [Related]
46. Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans.
Maurer L; Brachs S; Decker AM; Brachs M; Leupelt V; Jumpertz von Schwartzenberg R; Ernert A; Bobbert T; Krude H; Spranger J; Mai K
J Clin Endocrinol Metab; 2016 Nov; 101(11):4014-4020. PubMed ID: 27459526
[TBL] [Abstract][Full Text] [Related]
47. Studies of glucose intolerance in cirrhosis of the liver.
Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
[TBL] [Abstract][Full Text] [Related]
48. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
Goto T; Onuma T; Takebe K; Kral JG
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
[TBL] [Abstract][Full Text] [Related]
49. Hyperinsulinemia due to impaired insulin clearance associated with fasting hypoglycemia and postprandial hyperglycemia: an analysis of a patient with antiinsulin receptor antibodies.
Kiyokawa H; Kono N; Hamaguchi T; Kawachi M; Tajima K; Mineo I; Yamada Y; Shimizu T; Kuwajima M; Tarui S
J Clin Endocrinol Metab; 1989 Sep; 69(3):616-21. PubMed ID: 2668322
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
[TBL] [Abstract][Full Text] [Related]
51. Lack of insulin inhibition on insulin secretion in non-diabetic morbidly obese patients.
Muscelli E; Pereira JA; Lazarin MA; da Silva CA; Pareja JC; Saad MJ
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):798-804. PubMed ID: 11439292
[TBL] [Abstract][Full Text] [Related]
52. Insulin and renal sodium retention in obese adolescents.
Rocchini AP; Katch V; Kveselis D; Moorehead C; Martin M; Lampman R; Gregory M
Hypertension; 1989 Oct; 14(4):367-74. PubMed ID: 2676858
[TBL] [Abstract][Full Text] [Related]
53. Urine C-peptide as index of integrated insulin secretion in hypocaloric states in obese human subjects.
Yale JF; Leiter LA; Marliss EB
Diabetes; 1987 Apr; 36(4):447-53. PubMed ID: 3545945
[TBL] [Abstract][Full Text] [Related]
54. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity.
Meistas MT; Foster GV; Margolis S; Kowarski AA
Metabolism; 1982 Dec; 31(12):1224-8. PubMed ID: 6755165
[TBL] [Abstract][Full Text] [Related]
55. Assessment of hepatic insulin extraction from in vivo surrogate methods of insulin clearance measurement.
Asare-Bediako I; Paszkiewicz RL; Kim SP; Woolcott OO; Kolka CM; Burch M; Kabir M; Piccinini F; Bergman RN
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E605-E612. PubMed ID: 29509434
[TBL] [Abstract][Full Text] [Related]
56. An anomalous postprandial increase in erythrocyte insulin receptor affinity associated with hyperinsulinemia.
Ward GM; Harrison LC
Am J Clin Nutr; 1986 Jan; 43(1):160-6. PubMed ID: 3510526
[TBL] [Abstract][Full Text] [Related]
57. Hyperinsulinemia is associated with increasing insulin secretion but not with decreasing insulin clearance in an age-related metabolic dysfunction mice model.
Kurauti MA; Ferreira SM; Soares GM; Vettorazzi JF; Carneiro EM; Boschero AC; Costa-Júnior JM
J Cell Physiol; 2019 Jun; 234(6):9802-9809. PubMed ID: 30370604
[TBL] [Abstract][Full Text] [Related]
58. Current approaches to measurement of insulin secretion.
Polonsky KS; Rubenstein AH
Diabetes Metab Rev; 1986; 2(3-4):315-29. PubMed ID: 3527618
[TBL] [Abstract][Full Text] [Related]
59. Secretion and hepatic removal of insulin in female obese subjects with reactive hypoglycemia.
Bonora E; Coscelli C; Butturini U
Ann Nutr Metab; 1984; 28(5):305-10. PubMed ID: 6385813
[TBL] [Abstract][Full Text] [Related]
60. Further evidence for insulin hypersecretion not as an initial event but as a consequence of body growth and maturation in juvenile-onset obesity.
Maruhama Y; Hikichi I; Hashimoto T; Saito F; Ninomiya K
Diabetes Res Clin Pract; 1986 May; 2(2):83-90. PubMed ID: 3522150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
